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Infarcts of the brain occur in 15-50% of TIAs even though neurological signs and symptoms are absent. The role of patent foramen ovale (PFO) and atrial septal aneurysm (ASA) in the genesis of ischemic stroke in young adults has been investigated extensively over the past 20 years. (5, 6, 7) Recently, the importance of PFO as an etiological factor for stroke or TIA in older patients has been highlighted. (8) Whilst patients with PFOs may present predominantly with neurological episodes, non-neurological events such as peripheral and pulmonary emboli may also occur. A coagulation screen was included in the work-up of these patients.
Two were documented to have anti-phospholipid antibodies. The PFO occluder, attached to the delivery catheter, was then inserted and advanced to the tip of the catheter and the distal (left atrial) disc deployed immediately beyond the catheter tip. The device and sheath were then pulled back to allow the left atrial disc to align against the septum. The right atrial disc was then deployed. After checking for correct placement the device was released from the delivery catheter.
Seventeen patients had isolated
Coronary angiography was frequently done at the same time, particularly in the older subjects to exclude concomitant coronary artery disease. Patients are given clopidogrel for one month and then continued with low dose aspirin. and two with symptomatic atrial extrasystoles). In all 3 cases the arrhythmias had resolved within 6 months.
ILLUSTRATIVE EXAMPLES OF PATIENTS
A This was not an anticipated fi nding and the patient had not undergone formal assessment for ischemia prior to the PFO closure procedure. It
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was decided to intervene on the stenosis empirically, and a coronary stent was inserted. Post procedure the patient confi rmed that she had been experiencing episodes of angina-like chest pain.
A 31-year-old male had presented with a myocardial infarction at the age of 26 years that was thought to relate to the use of anabolic steroids. At that time, a right coronary artery stenosis was treated with stenting. He had been compliant with therapy including aspirin and statins. He subsequently presented to a neurologist complaining of headaches. A diagnosis of migraine was made, based upon his description of altered vision, which was thought to be a migraine aura.
On closer questioning it was evident that these were episodes of amaurosis fugax. A TEE showed a PFO which was closed and no further TIAs (or migraines) have occurred.
DISCUSSION
The presence of a patent foramen ovale (PFO) has been shown to be associated with an increased risk of ischemic stroke. (5, 6, 7) While this association has been predominantly shown in younger patients with unexplained (cryptogenic) stroke, it has also been suggested to be a factor in older patients. (5, 8, 11, 12) Patent foramen ovale is associated with right to left shunting. The
foramen ovale remains open in about one-fourth of the general population. The prevalence decreases with increasing age, from 34% during the fi rst three decades to 20% during the ninth decade. (13) The risk of paradoxical embolism increases with increasing size of PFO.
With each decade of life the size of the PFO increases, so that the mean diameter in the fi rst decade is 3.4mm, whilst in the tenth decade the mean size is 5.8mm. (12, 13) The role of PFO in the pathogenesis of ischemic stroke was suggested by a case controlled study in patients under 55 years of age with ischemic stroke detected by contrast echocardiographic examinations.
The prevalence of PFO was signifi cantly higher in the stroke group than in controls (40% vs. 10%; p < 0.001). Patent foramen ovale was found in 54% of stroke patients with no other identifi able cause. This study concluded that PFO associated paradoxical embolism was the cause of stroke. The subsequent PFO-ASA Study supported these conclusions, fi nding that 46% of young cryptogenic stroke patients had PFO. (14) It appears that patients with PFO have an increased prevalence of pelvic vein thrombosis. (15) In this study of young patients with cryptogenic stroke, pelvic vein thrombosis was more prevalent than in controls (20% vs. 4%). This may be the true source of the embolus with the PFO being the conduit that allows the embolus to cross to the systemic circulation.
A prospective study of 598 patients (ages 18 to 55 years) presenting with cryptogenic stroke showed that 36% had a PFO, 1.7% had an ASA, and 8.5% had both abnormalities. Patients with both PFO and ASA who have had a stroke are at higher risk for recurrent stroke despite continued therapy with aspirin. (6, 16) showed that the presence of PFO was independently associated with cryptogenic stroke in both age groups with odds ratio of 3.70 in the younger group and odds ratio of 3.00 in the older group.
Therapeutic options for patients with PFO with or without ASA, who present with a stroke or TIA include antiplatelet therapy with aspirin, dipyridimole or clopidogrel, oral anti-coagulation with warfarin, or closure of the defect surgically or percutaneously. Percutaneous closure of the defect is a well established procedure with a low complication rate in skilled hands. It is effective and associated with a lower rate of recurrent neurological events than medical therapy alone. This has been confi rmed in several observational studies and meta-analyses. (17, 18, 19, 20, 21) Our reported series demonstrates the importance of taking an adequate history, and not always accepting an "obvious" pathology as the cause of the neurological defi cit or vascular event. These cases emphasise the need to reassess patients, particularly when symptoms
